ArticleBio-protocol2022

Developing Clinically Relevant Acquired Chemoresistance Models in Epithelial Ovarian Cancer Cell Lines.

Priti S Shenoy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.